Format

Send to

Choose Destination
See comment in PubMed Commons below
Int J Mol Sci. 2011;12(8):5304-18. doi: 10.3390/ijms12085304. Epub 2011 Aug 17.

Reviewing ligand-based rational drug design: the search for an ATP synthase inhibitor.

Author information

1
Graduate Institute of Biomedical Electronics and Bioinformatics, National Taiwan University, Taipei 106, Taiwan; E-Mail: r99945042@ntu.edu.tw.

Abstract

Following major advances in the field of medicinal chemistry, novel drugs can now be designed systematically, instead of relying on old trial and error approaches. Current drug design strategies can be classified as being either ligand- or structure-based depending on the design process. In this paper, by describing the search for an ATP synthase inhibitor, we review two frequently used approaches in ligand-based drug design: The pharmacophore model and the quantitative structure-activity relationship (QSAR) method. Moreover, since ATP synthase ligands are potentially useful drugs in cancer therapy, pharmacophore models were constructed to pave the way for novel inhibitor designs.

KEYWORDS:

ATP synthase ligands; pharmacophore; quantitative structure-activity relationships

PMID:
21954360
PMCID:
PMC3179167
DOI:
10.3390/ijms12085304
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Multidisciplinary Digital Publishing Institute (MDPI) Icon for PubMed Central
    Loading ...
    Support Center